Enanta Pharmaceuticals Inc (ENTA)
13.78
+0.53
(+4.00%)
USD |
NASDAQ |
Apr 30, 11:14
Enanta Pharmaceuticals 1 Year Total Returns (Daily): -62.73% for April 29, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 29, 2024 | -62.73% |
April 26, 2024 | -64.20% |
April 25, 2024 | -64.09% |
April 24, 2024 | -64.48% |
April 23, 2024 | -64.26% |
April 22, 2024 | -63.47% |
April 19, 2024 | -64.25% |
April 18, 2024 | -64.60% |
April 17, 2024 | -63.17% |
April 16, 2024 | -57.95% |
April 15, 2024 | -55.79% |
April 12, 2024 | -55.04% |
April 11, 2024 | -56.79% |
April 10, 2024 | -57.84% |
April 09, 2024 | -57.79% |
April 08, 2024 | -58.95% |
April 05, 2024 | -57.11% |
April 04, 2024 | -58.35% |
April 03, 2024 | -58.04% |
April 02, 2024 | -59.57% |
April 01, 2024 | -57.91% |
March 28, 2024 | -55.02% |
March 27, 2024 | -58.49% |
March 26, 2024 | -60.19% |
March 25, 2024 | -65.21% |
Date | Value |
---|---|
March 22, 2024 | -63.24% |
March 21, 2024 | -64.22% |
March 20, 2024 | -65.25% |
March 19, 2024 | -66.64% |
March 18, 2024 | -67.90% |
March 15, 2024 | -68.07% |
March 14, 2024 | -69.32% |
March 13, 2024 | -67.96% |
March 12, 2024 | -67.75% |
March 11, 2024 | -66.56% |
March 08, 2024 | -67.35% |
March 07, 2024 | -66.61% |
March 06, 2024 | -66.63% |
March 05, 2024 | -68.30% |
March 04, 2024 | -67.06% |
March 01, 2024 | -68.74% |
February 29, 2024 | -70.37% |
February 28, 2024 | -70.52% |
February 27, 2024 | -70.48% |
February 26, 2024 | -70.73% |
February 23, 2024 | -72.55% |
February 22, 2024 | -74.58% |
February 21, 2024 | -73.50% |
February 20, 2024 | -74.74% |
February 16, 2024 | -73.55% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-82.00%
Minimum
Oct 27 2023
114.8%
Maximum
Nov 05 2021
-20.97%
Average
-25.26%
Median
Sep 03 2019
1 Year Total Returns (Daily) Benchmarks
Madrigal Pharmaceuticals Inc | -35.55% |
Galectin Therapeutics Inc | 104.5% |
Viking Therapeutics Inc | 253.9% |
Akero Therapeutics Inc | -56.15% |
89bio Inc | -46.62% |